These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3806617)
1. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. 2. Direct observation, characterization, and reactivity studies of iminocyclophosphamide and related species. Boyd VL; Summers MF; Ludeman SM; Egan W; Zon G; Regan JB J Med Chem; 1987 Feb; 30(2):366-74. PubMed ID: 3806617 [TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways. Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049 [TBL] [Abstract][Full Text] [Related]
3. Spectroscopic detection of iminocyclophosphamide and its possible role in cyclophosphamide metabolism. Kwon CH; Kirk MC; Struck RF; Borch RF J Med Chem; 1987 Jun; 30(6):1110-4. PubMed ID: 3585908 [TBL] [Abstract][Full Text] [Related]
4. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution. Borch RF; Hoye TR; Swanson TA J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051 [TBL] [Abstract][Full Text] [Related]
5. 31P nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites. Boyd VL; Robbins JD; Egan W; Ludeman SM J Med Chem; 1986 Jul; 29(7):1206-10. PubMed ID: 3543359 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide. Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of activation of 4-hydroxycyclophosphamide. Borch RF; Millard JA J Med Chem; 1987 Feb; 30(2):427-31. PubMed ID: 3806624 [TBL] [Abstract][Full Text] [Related]
8. Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism. Kwon CH; Borch RF; Engel J; Niemeyer U J Med Chem; 1987 Feb; 30(2):395-9. PubMed ID: 3806619 [TBL] [Abstract][Full Text] [Related]
9. Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide. Fenselau C; Lehman JP; Myles A; Brandt J; Yost GS; Friedman OM; Colvin OM Drug Metab Dispos; 1982; 10(6):636-40. PubMed ID: 6130913 [TBL] [Abstract][Full Text] [Related]
10. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide. Zon G; Ludeman SM; Sweet EM; Egan W; Phillips LR J Pharm Sci; 1982 Apr; 71(4):443-6. PubMed ID: 7086655 [TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance study of fibrinogen-like peptides and their structure in dimethyl sulfoxide and water. von Dreele PH; Rae ID; Scheraga HA Biochemistry; 1978 Mar; 17(6):956-62. PubMed ID: 629953 [TBL] [Abstract][Full Text] [Related]
12. Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate. Borch RF; Getman KM J Med Chem; 1984 Apr; 27(4):485-90. PubMed ID: 6708050 [TBL] [Abstract][Full Text] [Related]
13. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis. Low JE; Borch RF; Sladek NE Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981 [TBL] [Abstract][Full Text] [Related]
14. Multinuclear NMR (1H, 13C and 19F) spectroscopic re-examination of the solvolytic behaviour of flurazepam dihydrochloride. Dawson BA; Black DB; Neville GA J Pharm Biomed Anal; 1995 Apr; 13(4-5):395-407. PubMed ID: 9696548 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data. Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371 [TBL] [Abstract][Full Text] [Related]
16. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies. Sonawat HM; Leibfritz D; Engel J; Hilgard P Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593 [TBL] [Abstract][Full Text] [Related]
17. Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification. Ludeman SM; Shulman-Roskes EM; Wong KK; Han SY; Anderson LW; Strong JM; Colvin OM J Pharm Sci; 1995 Apr; 84(4):393-8. PubMed ID: 7629726 [TBL] [Abstract][Full Text] [Related]
18. The interaction of glutathione with 4-hydroxycyclophosphamide and phosphoramide mustard, studied by 31P nuclear magnetic resonance spectroscopy. Dirven HA; Venekamp JC; van Ommen B; van Bladeren PJ Chem Biol Interact; 1994 Dec; 93(3):185-96. PubMed ID: 7923439 [TBL] [Abstract][Full Text] [Related]
19. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide. Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506 [TBL] [Abstract][Full Text] [Related]
20. 1H- and 13C-NMR studies of solutions of hyaluronic acid esters and salts in methyl sulfoxide: comparison of hydrogen-bond patterns and conformational behaviour. Kvam BJ; Atzori M; Toffanin R; Paoletti S; Biviano F Carbohydr Res; 1992 Jun; 230(1):1-13. PubMed ID: 1511449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]